TriSalus Life Sciences, Inc. SEC filings TLSI

TriSalus Life Sciences, Inc. has 493 filings in SEC EDGAR's recent list, going back to Oct 29, 2020. Its latest annual report, Form ARS, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 22, 2026 (other events). The company's fiscal year ends on December 31.

TriSalus Life Sciences, Inc. SEC filings
Form Description Filed Period
DEFA14A Additional proxy material Mar 31, 2026 —
DEF 14A Proxy statement Mar 31, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 30, 2025 Jun 12, 2025
DEF 14A Proxy statement Jul 19, 2024 Jul 10, 2024
DEFA14A Additional proxy material Aug 2, 2023 —
DEF 14A Proxy statement May 24, 2023 Jun 12, 2023
PRE 14A Preliminary proxy statement May 9, 2023 May 9, 2023
DEFA14A Additional proxy material Dec 8, 2022 —
DEFA14A Additional proxy material Nov 28, 2022 —
DEF 14A Proxy statement Nov 7, 2022 Dec 7, 2022
PRE 14A Preliminary proxy statement Oct 24, 2022 Oct 24, 2022
DEFM14A Filing Feb 14, 2022 —
DEF 14A Proxy statement Feb 14, 2022 Mar 9, 2022

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
TLSI (Nasdaq), TLSIW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Westminster, CO
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1826667
Former names
MedTech Acquisition Corp (until Aug 10, 2023); MedTech Acquisition Corporation (until Oct 29, 2020)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.